Rybrevant Injection
Product Images NDC 57894-501

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Rybrevant (NDC 57894-501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Biotech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (7 mL Vial Carton)

Rybrevant® (amivantamab-vmiw) Injection is a medication used for intravenous infusion. It comes in a single-dose vial containing 350mg/7mL of amivantamab-vinj. It should be refrigerated at 7°C to 17°C and should be protected from light. Diluting prior to use is recommended. Unused portions should be discarded. It should not be frozen. This medication is manufactured by Janssen and is only available via prescription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.